Trials / Conditions / HER2-positive Colorectal Cancer
HER2-positive Colorectal Cancer
6 registered clinical trials studyying HER2-positive Colorectal Cancer — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who H NCT07384377 | Shanghai JMT-Bio Inc. | Phase 3 |
| Recruiting | A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871 | Iambic Therapeutics, Inc | Phase 1 |
| Not Yet Recruiting | KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma NCT05985707 | Peking University Cancer Hospital & Institute | Phase 2 |
| Recruiting | A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 NCT05514717 | Mersana Therapeutics | Phase 1 |
| Terminated | A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Can NCT05091528 | Silverback Therapeutics | Phase 1 / Phase 2 |
| Terminated | A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Exp NCT04278144 | Bolt Biotherapeutics, Inc. | Phase 1 / Phase 2 |